Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jamasurg.2022.6362 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Revolutionizing Breast Reconstruction: The Rise of Hybrid Techniques.
Medicina (Kaunas)
August 2025
Division of Plastic and Reconstructive Surgery, Northwell Health, Great Neck, NY 11021, USA.
Hybrid breast reconstruction (HBR) combines autologous tissue and bio-prosthetic breast reconstruction techniques. This method addresses many challenges associated with stand-alone techniques, including inadequate volume with autologous reconstruction and esthetic issues like rippling in implant-based reconstruction. However, despite its promising advantages, HBR remains underutilized.
View Article and Find Full Text PDFSurgical Treatment of Severe Aortic Stenosis: Sutureless Versus Stented Bioprosthetic Aortic Valve Replacement.
J Clin Med
August 2025
Cardiac Surgery Unit, Tor Vergata University, 00133 Rome, Italy.
The aim of this study is to analyze the effects of sutureless aortic valve bioprosthesis implantation compared with stented conventional bioprosthesis in patients with severe aortic stenosis. This is a propensity matching institutional study. : We compared 37 patients who underwent aortic valve replacement with Carpentier Edwards Perimount implantation (group 1) with 37 patients with sutureless Perceval S implanted (group 2).
View Article and Find Full Text PDFMid-Term Outcomes of Balloon-Expandable Aortic Valve-in-Valve Replacement in the United States.
JACC Cardiovasc Interv
August 2025
Division of Cardiothoracic Surgery, Washington University in St. Louis, St. Louis, Missouri, USA.
Background: Aortic valve-in-valve (AViV) replacement for is approved for patients with degenerated surgical valves at high or prohibitive surgical risk, mostly on the basis of small series with short-term follow-up.
Objectives: The aim of this study was to analyze the outcomes of AViV therapy using contemporary balloon-expandable valves (BEVs) in a large series with mid-term outcomes.
Methods: BEV AViV patients (June 2015 to December 2023) in the Society for Thoracic Surgeons (STS)/American College of Cardiology TVT (Transcatheter Valve Therapy) Registry were propensity matched to native transcatheter aortic valve replacement (TAVR) patients.
Fever, Malaise, and Weight Loss in a Woman With Aortic Valve Replacement.
JAMA
August 2025
Department of Internal Medicine, Stadtspital Zürich, Switzerland.
Transcatheter valve-in-valve mitral valve replacement with SAPIEN 3 valve for bioprosthetic mitral valve failure: one-year outcomes in 26 patients.
Zhejiang Da Xue Xue Bao Yi Xue Ban
August 2025
Department of Cardiovascular Surgery, Institute of Cardiovascular Surgery, West China Hospital, Sichuan University.
Objectives: To evaluate the one-year outcomes of valve-in-valve transcatheter mitral valve replacement (ViV-TMVR) using the SAPIEN 3 valve for treating mitral bioprosthetic valve failure.
Methods: A retrospective analysis was conducted on 26 patients with mitral bioprosthetic valve failure who underwent ViV-TMVR at West China Hospital, Sichuan University, between November 2022 and July 2024. The age of patients was 71.